|
On Wed, 11 Nov 2009 23:22:01 GMT, "socialist that fear the truth but want to give up all their rights" <.....Obama.......the..saviour....@whitehouse,New.World.Order.UN.Global
Conflicts of interest? Dr. Mehmet Oz owns 150,000 option shares in vaccine...
Started by socialist that fear the truth but want to give up all their rights on
, 3 posts
by 2 people.
Answer Snippets (Read the full thread at omgili):
Why do you think the media and government.
As the political potato heads who have shares in big
pharma.
|
|
Roche offers to acquire the 44% that it doesn't already own in Genentech for $89 a share or $43.7 billion in an all-cash deal. This should provide plenty of liquidity to the US biotech industry over the next several weeks.
http://www.marketwatch.com/news...
Started by HenryTo on
, 8 posts
by 2 people.
Answer Snippets (Read the full thread at marketthoughts):
Shares of GTC Therapeutics rose 5 cents, or 5.5.
The drug received European approval in 2006.
And clinics should slow market share losses while upholding pricing power and profitability for biotech.
|
|
Ersatzinvestment: Schaut auch mal "Immunogen" an, da bin ich schon investiert. (keine Anlageempfehlung, nur ein Tipp) Dort sollen Ergebnisse der Phase 3 Studie (in Kooperation mit Genentech/Roche wohl im Laufe des ersten Halbjahres herauskommen, Medikament...
Started by MasaRatti on
, 30 posts
by 9 people.
Answer Snippets (Read the full thread at wallstreet-online):
A subsidiary of Amgen will buy at least a majority of Microment’s outstanding shares....
The offer of $11 a share, plans to acquire Micromet’s shares in two phases.
A biotechnology company that develops cancer drugs, for $1.16 billion .
|
Ask your Facebook Friends
|
Biogen 4Q Profit Up 25% On Tysabri Sales Growth; Year View Weak 01/31 07:32 AM
DOW JONES NEWSWIRES
Biogen Idec Inc.'s (BIIB:$116.58,00$-1.98,00-1.67%) fourth-quarter earnings rose 25% as the biopharmaceutical company saw revenue grow faster than expected...
Started by usa11706 on
, 5 posts
by 4 people.
Answer Snippets (Read the full thread at investorvillage):
|
|
NEW YORK (AP) -- Facebook made a much-anticipated status update Wednesday: The Internet social network is going public eight years after its computer-hacking CEO Mark Zuckerberg started the service at Harvard University.
That means anyone with the right...
Started by davidbugs on
, 4 posts
by 2 people.
Answer Snippets (Read the full thread at emoneyspace):
Who Is consider Qutting Facebook? Since It got too big?
Facebook doesn't pay their users? anyone As much as I hate all the changes and security issues, EVERYONE has it, so it'd be silly to use a different social network
I use Twitter as well, but it doesn... .
|
|
I just noticed this stock today and have only read the posts here...and have yet to study the company's data...which I shall do.
I want to find out how far BTI is from first stage clinical trials with selected patients...then, if approved to move forward...
Started by Sinbob on
, 16 posts
by 1 people.
Answer Snippets (Read the full thread at stockhouse):
BTI tissue to the brain that can be attacked ... .
Result in the dilution of its intellectual property or its outstanding shares or that could limit that could create negative pressure (shorting, for instance) on the company’s share price.
|
|
First, in deference to our colleagues: Letting you guys go due to their mistakes is reprehensible. Yeah so it's a kinder kick in the AS_ (you can come back to company), but it will disrupt/destroy for a while so many lives.
Now on to Xolair: I urge all...
Answer Snippets (Read the full thread at cafepharma):
I've done it, and so have some of my are they??? Independent oncology AICs? Patients enrolled in studies???? Genentech gets credit for both other Xolair reps know I have printed ....
You got paid (MIR), with the monthly data from Genentech.
|
|
Zu diesem amerikanischen Pharmatitel fehlt einfach ein aktueller Thread :-)
Nachrichten gibts unter http://investor.incyte.com/ Angehängte Grafik: incyte-pipeline.jpg (verkleinert auf 86%)
* * *
"Die Menschen sind komische Leute." melden 24 Postings ausgeblendet...
Started by Vermeer on
, 25 posts
by 3 people.
Answer Snippets (Read the full thread at ariva):
Or $0.24 per diluted share, compared to net loss of $88.44 million, or $0.74 per diluted share, or $0.26 per diluted share, compared to net loss of $211.87 million, or $2.06 per diluted share-buy-009.htm hab mich heute von....
|
|
Chairman Steve Jobs left Apple . استقالة ستيف جوبز الرئيس التنفيذي لشركة ابل Steve Jobs resigns as chief executive from Apple: resignation letter in full
كلنا يعلم اليوم عن الخبر الحزين سواء لمحبي شركة أبل أو معارضيها، والذي تمثل باستقالة مؤسس الشركة ...
Started by Mohamed Fouad on
, 1 posts
by 1 people.
Answer Snippets (Read the full thread at egyeng):
|